Nash MA - Search Results

1

Sea urchin maternal and embryonic U1 RNAs are spatially segregated in early embryos.

Nash MA, Kozak SE, Angerer LM, Angerer RC, Schatten H, Schatten G, Marzluff WF. Nash MA, et al. J Cell Biol. 1987 May;104(5):1133-42. doi: 10.1083/jcb.104.5.1133. J Cell Biol. 1987. PMID: 3553205 Free PMC article.

2

A developmental switch in sea urchin U1 RNA.

Nash MA, Sakallah S, Santiago C, Yu JC, Marzluff WF. Nash MA, et al. Dev Biol. 1989 Aug;134(2):289-96. doi: 10.1016/0012-1606(89)90101-2. Dev Biol. 1989. PMID: 2744233

3

Structure of an unusual sea urchin U1 RNA gene cluster.

Nash MA, Marzluff WF. Nash MA, et al. Gene. 1988 Apr 15;64(1):53-63. doi: 10.1016/0378-1119(88)90480-5. Gene. 1988. PMID: 2969351

4

Structure and expression of a second sea urchin U1 RNA gene repeat.

Yu JC, Nash MA, Santiago C, Marzluff WF. Yu JC, et al. Among authors: nash ma. Nucleic Acids Res. 1986 Dec 22;14(24):9977-88. doi: 10.1093/nar/14.24.9977. Nucleic Acids Res. 1986. PMID: 3808958 Free PMC article.

5

Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.

Nash MA, Platsoucas CD, Wong BY, Wong PM, Cottler-Fox M, Otto E, Freedman RS. Nash MA, et al. Hum Gene Ther. 1995 Nov;6(11):1379-89. doi: 10.1089/hum.1995.6.11-1379. Hum Gene Ther. 1995. PMID: 8573611

6

The expression of decorin in human ovarian tumors.

Nash MA, Deavers MT, Freedman RS. Nash MA, et al. Clin Cancer Res. 2002 Jun;8(6):1754-60. Clin Cancer Res. 2002. PMID: 12060613

7

Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.

Freedman RS, Kudelka AP, Kavanagh JJ, Verschraegen C, Edwards CL, Nash M, Levy L, Atkinson EN, Zhang HZ, Melichar B, Patenia R, Templin S, Scott W, Platsoucas CD. Freedman RS, et al. Clin Cancer Res. 2000 Jun;6(6):2268-78. Clin Cancer Res. 2000. PMID: 10873077 Clinical Trial.

8

Activity of ALRT 1550, a new retinoid, with interferon-gamma on ovarian cancer cell lines.

Hu W, Verschraegen CF, Wu WG, Nash M, Freedman RS, Kudelka A, Kavanagh JJ. Hu W, et al. Int J Gynecol Cancer. 2002 Mar-Apr;12(2):202-7. doi: 10.1046/j.1525-1438.2002.01084.x. Int J Gynecol Cancer. 2002. PMID: 11975681

9

Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.

Lenzi R, Rosenblum M, Verschraegen C, Kudelka AP, Kavanagh JJ, Hicks ME, Lang EA, Nash MA, Levy LB, Garcia ME, Platsoucas CD, Abbruzzese JL, Freedman RS. Lenzi R, et al. Among authors: nash ma. Clin Cancer Res. 2002 Dec;8(12):3686-95. Clin Cancer Res. 2002. PMID: 12473577 Clinical Trial.

10

Quantitative analysis of transforming growth factor beta 1 and 2 in ovarian carcinoma.

Gordinier ME, Zhang HZ, Patenia R, Levy LB, Atkinson EN, Nash MA, Katz RL, Platsoucas CD, Freedman RS. Gordinier ME, et al. Among authors: nash ma. Clin Cancer Res. 1999 Sep;5(9):2498-505. Clin Cancer Res. 1999. PMID: 10499625

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page